While Wall Street Naps, These 10 Stocks Run Wild

4. Roivant Sciences Ltd. (NASDAQ:ROIV)

Roivant Sciences ended a three-day losing streak on Thursday, jumping 6.4 percent to finish at $11.30 each, as investors resorted to bargain-hunting, shunning its dismal earnings performance in the past quarter of the year.

On the same day, Roivant Sciences Ltd. (NASDAQ:ROIV) widened its attributable net loss by 36 percent to $206 million in the fourth quarter of fiscal year 2025, from $151 million in the same period last year. Revenues dropped by 16 percent to $7.57 billion from $9.02 billion year-on-year.

For the full fiscal year period, Roivant Sciences Ltd. (NASDAQ:ROIV) swung to an attributable net loss of $171.98 million from a $ 4.35 billion attributable net income a year earlier.

Revenues, on the other hand, dropped by 11 percent to $29 billion from $32.7 billion year-on-year.